Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Bone Marrow Mesenchymal Stem Cells to Heal Chronic Diabetic Wounds

  • Post author:
  • Post published:February 20, 2026
  • Post category:

Diabetic foot ulcers (DFU), chronic, non-healing wounds on the feet of diabetic patients, present a serious challenge to global health. These ulcers affect between 15-25% of the 18-21 million Americans…

Continue ReadingBone Marrow Mesenchymal Stem Cells to Heal Chronic Diabetic Wounds

Stem cell-based carriers for RCR vector delivery to glioblastoma

  • Post author:
  • Post published:February 20, 2026
  • Post category:

Modified viruses can be used to infect tumor cells and alter the tumor cell to make anti-tumor proteins. Most researchers use virus that can infect and modify the tumor cell…

Continue ReadingStem cell-based carriers for RCR vector delivery to glioblastoma

Human retinal progenitor cells as candidate therapy for retinitis pigmentosa

  • Post author:
  • Post published:February 20, 2026
  • Post category:

The targeted disease is retinitis pigmentosa (RP), is a severe form of blindness that runs in families. This disease is not overly common, yet represents an attainable near term target…

Continue ReadingHuman retinal progenitor cells as candidate therapy for retinitis pigmentosa

Banking transplant ready dopaminergic neurons using a scalable process

  • Post author:
  • Post published:February 20, 2026
  • Post category:

Parkinson's disease (PD) is a devastating movement disorder caused by the death of dopaminergic neurons (a type of nerve cells in the central nervous system) present in the midbrain. These…

Continue ReadingBanking transplant ready dopaminergic neurons using a scalable process

A hESc-based Development Candidate for Huntington’s Disease

  • Post author:
  • Post published:February 20, 2026
  • Post category:

Huntington’s disease (HD) is a devastating degenerative brain disease with a 1 in 10,000 prevalence that inevitably leads to death. These numbers do not fully reflect the large societal and…

Continue ReadingA hESc-based Development Candidate for Huntington’s Disease

Development of Cellular Therapies for Retinal Disease

  • Post author:
  • Post published:February 20, 2026
  • Post category:

The long term goal of our research program is regeneration of the diseased eye. Age-related macular degeneration, diabetic retinopathy, and retinitis pigmentosa are leading causes of blindness for which there…

Continue ReadingDevelopment of Cellular Therapies for Retinal Disease

Developmental Candidates for Cell-Based Therapies for Parkinson’s Disease (PD)

  • Post author:
  • Post published:February 20, 2026
  • Post category:

Parkinson's Disease (PD) is a devastating disorder, stealing vitality from vibrant, productive adults & draining our health care dollars. It is also an excellent model for studying other neurodegenerative conditions.…

Continue ReadingDevelopmental Candidates for Cell-Based Therapies for Parkinson’s Disease (PD)

Stem Cell-Based Therapy for Cartilage Regeneration and Osteoarthritis

  • Post author:
  • Post published:February 20, 2026
  • Post category:

Arthritis is the result of degeneration of cartilage (the tissue lining the joints) and leads to pain and limitation of function. Arthritis and other rheumatic diseases are among the most…

Continue ReadingStem Cell-Based Therapy for Cartilage Regeneration and Osteoarthritis

Embryonic-Derived Neural Stem Cells for Treatment of Motor Sequelae following Sub-cortical Stroke

  • Post author:
  • Post published:February 20, 2026
  • Post category:

A stroke kills brain cells by interrupting blood flow. The most common “ischemic stroke” is due to blockage in blood flow from a clot or narrowing in an artery. Brain…

Continue ReadingEmbryonic-Derived Neural Stem Cells for Treatment of Motor Sequelae following Sub-cortical Stroke

Stem Cell-Derived Astrocyte Precursor Transplants in Amyotrophic Lateral Sclerosis

  • Post author:
  • Post published:February 20, 2026
  • Post category:

Amyotrophic lateral sclerosis (ALS), a lethal disease lacking effective treatments, is characterized by the loss of upper and lower motor neurons. 5-10% of ALS is familial, but the majority of…

Continue ReadingStem Cell-Derived Astrocyte Precursor Transplants in Amyotrophic Lateral Sclerosis
  • Go to the previous page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us